ACH
CBAY

ArrowMark Colorado Holdings’s Cymabay Therapeutics CBAY Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-179,400
Closed -$4.24M – 336
2023
Q4 		$4.24M Hold
179,400
– – 0.05% 214
2023
Q3 		$2.67M Buy
+179,400
New +$2.38M 0.03% 220

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ArrowMark Colorado Holdings's CBAY Position: Q1 2024 in Review

ArrowMark Colorado Holdings sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 179,400 shares — an estimated $4.24M sold.

ArrowMark Colorado Holdings first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $4.24M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • ArrowMark Colorado Holdings reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 179,400 Cymabay Therapeutics shares in Q1 2024, an estimated $4.24M.
  • ArrowMark Colorado Holdings first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • ArrowMark Colorado Holdings's Cymabay Therapeutics position peaked at $4.24M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2024, filed 15 May 2024.